AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the...
WASHINGTON: US health authorities confirmed on Friday that data provided by drug-maker Moderna on the efficacy of its Covid-19 vaccine among very young children...
The South African health regulator said on Monday it has registered Chinese COVID-19 vaccine Sinopharm, effectively clearing the way for its use in the...
ISLAMABAD: Pakistan has received 15 million doses of COVID-19 vaccine from the Asian Development Bank (ADB), ARY News reported.
As per details, 15 million doses...
ISLAMABAD: Pakistan has achieved another milestone of vaccinating half the country's population eligible for coronavirus vaccine with at least one dose.
Besides, the country made...
ISLAMABAD: The Economic Coordination Committee (ECC) on Thursday approved a technical supplementary grant worth $190 million to the National Disaster Management Authority (NDMA) for...
The director of the US Centers for Disease Control and Prevention (CDC) on Tuesday backed broad use of Pfizer's and BioNTech's COVID-19 vaccine in children...
The World Health Organization said on Thursday it was about to restart the process of approving Russia's Sputnik V Covid-19 vaccine following a series...
Canadian health officials said on Friday data suggests reported cases of rare heart inflammation were relatively higher after Moderna's COVID-19 vaccine compared with the...
FAISALABAD: A gang has activated in Faisalabad whose members were allegedly administering COVID-19 vaccine to the citizens after charging Rs200 in Awan Wala, ARY...
Three US studies suggest COVID-19 vaccines offer strong protection against hospitalization and death, even in the face of the highly transmissible Delta variant, but...
Highly allergic adults can safely receive the COVID-19 vaccine from Pfizer/BioNTech, a new study suggests.
Among the 8,102 patients with allergies in the Israeli study,...
LIMA/BEIJING: A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a...